ProPhase Labs, Inc. Profile Avatar - Palmy Investing

ProPhase Labs, Inc.

ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic…

Drug Manufacturers - Specialty & Generic
US, Garden City [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

ProPhase Labs, Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of PRPH's Analysis
CIK: 868278 CUSIP: 74345W108 ISIN: US74345W1080 LEI: - UEI: -
Secondary Listings
PRPH has no secondary listings inside our databases.